Showing 61 - 80 results of 110 for search '"Genomics England"', query time: 0.32s Refine Results
  1. 61
  2. 62

    Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project by John Bridgewater, Xiaolong Jiao, Mounika Parimi, Clare Flach, Jeran Stratford, Atanas Kamburov, Arndt A. Schmitz, Jihong Zong, John A. Reeves, Karen Keating, Amanda Bruno, Marc Fellous, Mariana Buongermino Pereira, Lyudmila Bazhenova

    Published 2022-01-01
    “…Materials and Methods: This retrospective study included patients enrolled in the Genomics England 100,000 Genomes Project who had linked clinical data from UK databases. …”
    Get full text
    Article
  3. 63
  4. 64
  5. 65

    Robustness of Massively Parallel Sequencing Platforms. by Pınar Kavak, Bayram Yüksel, Soner Aksu, M Oguzhan Kulekci, Tunga Güngör, Faraz Hach, S Cenk Şahinalp, Turkish Human Genome Project, Can Alkan, Mahmut Şamil Sağıroğlu

    Published 2015-01-01
    “…The improvements in high throughput sequencing technologies (HTS) made clinical sequencing projects such as ClinSeq and Genomics England feasible. Although there are significant improvements in accuracy and reproducibility of HTS based analyses, the usability of these types of data for diagnostic and prognostic applications necessitates a near perfect data generation. …”
    Get full text
    Article
  6. 66

    RSDB: A rare skin disease database to link drugs with potential drug targets for rare skin diseases by Tien-Chueh Kuo, Pei-Hua Wang, Yu-Ke Wang, Chia-I. Chang, Ching-Yao Chang, Yufeng Jane Tseng

    Published 2022-08-01
    “…Measurement(s) Relationships between chemicals and genes • Relationships between diseases and genes • Relationships between diseases and phenotypes • Relationships between genes and phenotypes Technology Type(s) The Comparative Toxicogenomics Database (CTD) and DrugBank • DisGeNET, UniProt, The Comparative Toxicogenomics Database (CTD), Orphanet, ClinGen, Genomics England, NCBI ClinVar, The Human Phenotype Ontology (HPO), the GWAS Catalog, GWASdb28, the LHGDN and BeFree system • The Human Phenotype Ontology (HPO) and Genetic and Rare Diseases Information Center (GARD) Sample Characteristic - Organism Homo sapiens…”
    Get full text
    Article
  7. 67

    Managing expectations, rights, and duties in large-scale genomics initiatives: a European comparison by Horn, RJ, Merchant, J

    Published 2022
    “…Our geographic scope of comparative analysis includes initiatives underway in England (Genomics England), France (Plan France Médecine Génomique) and Germany (German Human Genome-Phenome Archive). …”
    Journal article
  8. 68

    Evaluating the performance of a clinical genome sequencing program for diagnosis of rare genetic disease, seen through the lens of craniosynostosis by Hyder, Z, Calpena, E, Pei, Y, Tooze, RS, Twigg, SRF, Wilkie, A, Et al.

    Published 2021
    “…We evaluated the performance of the Genomics England 100,000 Genomes Project (100kGP) panel-based pipelines, using craniosynostosis as a test disease.…”
    Journal article
  9. 69

    The ethics of genomic medicine: redefining values and norms in the UK and France by Gaille, M, Horn, R

    Published 2021
    “…In 2018, the two countries announced enhanced cooperation between their national strategies, Genomics England and Plan France Médecine Génomique 2025, which offers a unique opportunity to study the impact of genomic medicine and relevant policies in different national contexts. …”
    Journal article
  10. 70

    Genomic landscape of adult testicular germ cell tumours in the 100,000 Genomes Project by Ní Leathlobhair, M, Frangou, A, Kinnersley, B, Cornish, AJ, Chubb, D, Lakatos, E, Arumugam, P, Gruber, AJ, Law, P, Tapinos, A, Jakobsdottir, GM, Peneva, I, Sahli, A, Smyth, EM, Ball, RY, Sylva, R, Benes, K, Stark, D, Young, RJ, Lee, ATJ, Wolverson, V, Houlston, RS, Sosinsky, A, Protheroe, A, Wedge, DC, Verrill, C

    Published 2024
    “…Leveraging samples from participants recruited via the UK National Health Service and data from the Genomics England 100,000 Genomes Project, our results provide an extended description of genomic elements underlying TGCT pathogenesis. …”
    Journal article
  11. 71
  12. 72

    Fostering public trust in national health data platforms: key considerations for public involvement activities for England and Switzerland by Paola Daniore, Katherine-Helen Hurndall, Federica Zavattaro, Melanie Leis, Felix Gille

    Published 2025-01-01
    “…In this commentary, we refer to three national research programs, namely the UK Biobank, Genomics England, and the Swiss Health Study, which implemented effective public involvement activities and achieved high participation rates. …”
    Get full text
    Article
  13. 73

    Association between tumour somatic mutations and venous thromboembolism in the 100,000 Genomes Project cancer cohort: a study protocol [version 2; peer review: 2 approved] by Naomi Cornish, Matthew T. Warkentin, Sarah K. Westbury, Andrew D. Mumford, Chrissie Thirlwell, Philip C. Haycock

    Published 2024-12-01
    “…We plan to examine the association between tumour somatic mutations and VTE in an existing cohort of patients with cancer, who were enrolled to the flagship Genomics England 100,000 Genomes Project. Here, we outline an a-priori analysis plan to address this objective, including details on study cohort selection, exposure and outcome definitions, annotation of genetic variants and planned statistical analyses. …”
    Get full text
    Article
  14. 74
  15. 75

    Ethical issues raised by new genomic technologies: the case study of newborn genome screening by Rachel Horton, Anneke Lucassen

    Published 2023-01-01
    “…This aims to ensure timely diagnosis, access to treatment pathways, and enable better outcomes and quality of life for babies and their families’ (Genomics England, 2021). This is a laudable aim, but the path from obtaining genome sequences to enabling better outcomes will not be straightforward and illustrates many of the ethical challenges raised by the use of new genomic technologies. …”
    Get full text
    Article
  16. 76

    A comparison of structural variant calling from short-read and nanopore-based whole-genome sequencing using optical genome mapping as a benchmark by Pei, Y, Tanguy, M, Giess, A, Dixit, A, Wilson, LC, Gibbons, RJ, Twigg, SRF, Elgar, G, Wilkie, AOM

    Published 2024
    “…We prepared high-quality DNA from 9 parent–child trios, who had previously undergone short-read whole-genome sequencing (Illumina platform) as part of the Genomics England 100,000 Genomes Project. We reanalysed the genomes using both Bionano optical genome mapping (OGM; 8 probands and one trio) and Nanopore long-read sequencing (Oxford Nanopore Technologies [ONT] platform; all samples). …”
    Journal article
  17. 77

    The use of biomedical big data for economic analyses of genome sequencing in rare genetic diseases: a case study from the 100,000 Genomes Project by Fahr, P

    Published 2021
    “…This thesis explores the use of BBD for economic analyses of genomic diagnostics in rare genetic diseases in the context of the Genomics England 100,000 Genomes Project (100KGP) and the National Health Service (NHS) in England.…”
    Thesis
  18. 78
  19. 79
  20. 80